期刊文献+

润肤剂在特应性皮炎基础治疗中应用的研究进展 被引量:5

Progress in Clinical Application of Emollient in the Basic Treatment of Atopic Dermatitis
原文传递
导出
摘要 特应性皮炎是一种慢性、复发性和炎症性皮肤病,以皮肤干燥、瘙痒和湿疹样外观为主要临床表现。其发病机制复杂,皮肤屏障功能障碍可能是其发生的源头。保湿润肤剂可以补充皮肤水分和脂质,增加水合作用,减少经皮失水率,阻止外界有害物质入侵。润肤剂联合糖皮质激素治疗还可以减少激素用量,减轻其不良反应。传统的润肤剂含有非生理性脂质和表面活化剂,长期应用会破坏皮肤屏障含有神经酰胺的润肤剂作为本病的基础治疗方案,已被应用于各种年龄段的患者中,且耐受性好,也无严重的不良反应,故具有较高的安全性和有效性。 Atopic dermatitis(AD) is a chronic, recurrent inflammatory disease, with xerosis curls, pruritus and eczema appearance as the main clinical manitestations. Its pathogenesis was complicated. Dysfunction of skin barrier may be the cause of the disease. Emollient could replenish skin moisture and lipid, increase the hydration, reduce the trans-epidermal water loss and block the invasion of harmful substances. A combination treatment of emollient and glucocorticoid could reduce the dosage of glucocortieoids and reduce its side effects. The tra- ditional emollient contains non-physiologic lipids and surfactants, and long-term use can damage the skin barrier. Ceramide-containing emollient, a basic treatment for AD, has been used in various age groups of pa- tients with good tolerability and without serious untoward reactions, so it has higher safety and effectiveness.
作者 杨欢 王华
出处 《中国皮肤性病学杂志》 CAS 北大核心 2014年第1期81-83,共3页 The Chinese Journal of Dermatovenereology
关键词 特应性皮炎 保湿 润肤剂 皮肤屏障 Atopic Dermatitis Moisturize Emollient Skin barrier
  • 相关文献

参考文献28

  • 1Bieber T. Atopic dermatitis [ J ]. Ann Derma- to1,2010,22 (2) : 125-137.
  • 2Elias PM, Wood LC, Feingold KR. Epider- mal pathogenesis of inflammatory dermatoses [J]. Am J Contact Dermat, 1999,10 ( 3 ) : 119-126.
  • 3Taieb A. Hypothesis:from epidermal barrier dysfunction to atopic disorders [J]. Contact Dermatitis, 1999,41 (4) : 177-180.
  • 4Groen D, Poole DS, Gooris GS, et al. Is an orthorhombic lateral packing and a proper lamellar organization important for the skin barrier function.'? [ J ] Biochim Biophys Ac- ta, 2011,1808 ( 6 ) : 1529-1537.
  • 5Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009 [ J]. J Allergy Clin Immuno1,2010,125(1) :16-29.
  • 6Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic der- matitis [ J ]. J Invest Dermatol, 2009, 129 (8) :1892-1908.
  • 7Jakasa I, Koster ES, Calkoen F, et al. Skin barrier function in healthy subjects and pa- tients with atopic dermatitis in relation to filaggrin loss-of-function mutations[ J]. J In- vest Dermato1,2011 , 131 (2) :540-542.
  • 8Nemoto-Hasebe I, Akiyama M, Nomura T, et al. Clinical severity correlates with impaired barrier in filaggrin-related eczema[ J ]. J In- vest Dermato1,2009,129 ( 3 ) :6824589.
  • 9Barker JN, Palmer CN, Zhao Y, et al. Null mutations in the filaggrin gene(FLG) deter- mine major susceptibility to early, onset topic dermatitis that persists into adulthood [ J ]. J Invest Dermato1,2007,127 ( 3 ) :564-567.
  • 10O'Regan GM, Irvine AD. The role of filag- grin in the atopic diathesis [ J ]. Clin Exp Allergy,2010,40 (7) :965-972.

二级参考文献16

  • 1Leung DY,Boguniewicz M,Howell MD,et al.New insights into atopic dermatitis[J].J Clin Invest,2004,113(5):651-657.
  • 2Charman CR,Morris AD,Williams HC.Topical corticosteroid phobia in patients with atopic eczema[J].Br J Dermatol,2000,142(5):931-936.
  • 3Elias PM,Hatano Y,Williams ML.Basis for the barrier abnormality in atopic dermatitis:outside-inside-outside pathogenic mechanisms[J].J Allergy Clin Immunol,2008,121 (6):1337-1343.
  • 4Hakozaki T,Minwalla L,Zhuang J,et al.The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer[J].Br J Dermatol,2002,147(1):20-31.
  • 5Harding C R. The stratum corneum, structure and function in health and disease [J]. Dermatol Ther, 2004, 17 Suppll : 6 - 15.
  • 6Elias P. Integrated functions of the stratum corneum : implications for an optimal skin care regimen [ R ]. Skin Allergy News, 2005. 6.
  • 7Elias P M, Feingold K R. Lipid-related barriers and gradients in the epidermis [JJ. Ann N Y Acad Sci, 1988, 548:4 - 13.
  • 8Rawlings A. Dry and xerotic skin conditions [ A ]. In : JJ Leyden, AV Rawlings (Eds). Skin moisturization [ M ]. New York : Marcel Dekker, Inc. , 2002, 119 - 144.
  • 9Epstein H A. Anatomy of a skin cleanser [ J]. Skinmed, 2005, 4 (3): 183 - 185.
  • 10Abbas S, Goldberg J W, Massaro M. Personal cleanser technology and clinical performance [ J]. Dermatol Ther, 2004, 17 Suppll: 35 - 42.

共引文献27

同被引文献38

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部